2 min read
Triangle Perspective on AI, ML, & the Future of Drug Development
Veristat Announces Participation in the "Triangle Perspective on AI, ML, & the Future of Drug Development" Panel...
1 min read
We are pleased to announce that Shayesteh Fürst-Ladani, will speak about “How much clinical data from medical device studies is enough to support application for CE Certification? ” in the Roundtable organized from 9:00-10:30 am.
Don’t miss Shayesteh and the full line-up of experts convening to discuss the very latest clinical and regulatory updates.
Chair: Ghazaleh Gouya, Priv. Doz Dr. med Cardiologist, Founder of Gouya insights, GPMed Board Member & IFAPP Board Member
Speakers:
‘Design of clinical MD investigations and approvable endpoints’
Dr. Andreas Beust, Chief Scientific Officer, GCP-Service International Ltd. & Co. KG
‘ How much clinical data from Medical Device studies is enough for CE mark?"
Shayesteh Fürst-Ladani, MBA, MSc, GFMD, Senior Vice President SFL, Head of SFL Group
‘Guidance documents"
Tom Melvin, Associate Professor of Medical Device Regulatory Affairs, School of Medicine, Trinity College
Website: https://www.icpm2022.gr/
2 min read
Jun 7, 2024 Veristat Events
Veristat Announces Participation in the "Triangle Perspective on AI, ML, & the Future of Drug Development" Panel...
2 min read
May 3, 2024 Veristat Events
Meet the Veristat team at ASCO, May 31st to June 4th in Chicago
The Science-First CRO™ and Consultancy Ready to...